Wczytywanie spółki
Just reported
Q3 2026 results
From Teleflex's results release of 5 listopada 2026; its quarterly report has since been filed.
Revenue
Actual
567,8M USD
+0,1% y/y
-0,4% q/qGuided
—
No guide given
EPS, GAAP
Actual
22,28 USD
Guided
—
No guide given
Operating income, GAAP
Actual
105,4M USD
+45% q/q
Guided
—
No guide given
Company outlook
Full year 2026
- EPS, adjusted7,50 USD – 7,75 USDRaised +8,2%
- EPS, GAAP2,84 USD – 3,09 USDRaised +10%
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Keep exploring
The themes Teleflex is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Medical Instruments and Supplies
Graded A or B and worth $2B or more: A first, then the largest.
ISRGIntuitive Surgical, Inc.152,5B USDA+
MDLNMedline Inc.52,6B USDA
ALCAlcon Inc.35B USDA
BLCOBausch & Lomb Corp7,6B USDA-
ATRCAtriCure, Inc.2,9B USDA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 paź 2026CBGraded C, now B
MCKMckesson Corporation4 lis 2026BAGraded B, now A
CVSCVS Health Corp4 lis 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 lis 2026BAGraded B, now A
BIIBBiogen Inc.28 paź 2026BAGraded B, now A
Pełne sprawozdania finansowe →
Zbudowane z własnych raportów spółki Teleflex Incorporated składanych do amerykańskiej Komisji Papierów Wartościowych i Giełd (SEC). Liczby są takie, jak zaraportowano, a historia na akcję przeliczona na dzisiejszą bazę akcji. To opisuje firmę — nie jest poradą inwestycyjną ani rekomendacją kupna lub sprzedaży.
